SP

Signal Pharmaceuticals

Acquired
Business Model
B2B
Last Round
Series AJan 1994
Rounds
2
Acquired by
CelgeneJul 2000

About

Signal Pharmaceuticals was a San Diego, California-based biotechnology company focused on discovering new classes of drugs that regulate genes associated with disease through signal transduction research. Co-founded by UCSD researcher Michael Karin, the company pursued a novel approach to drug discovery based on the regulation of gene expression — targeting signaling pathways that control disease-related genes rather than the genes themselves. Signal Pharmaceuticals conducted research into IkB Kinase (IKK) and related inflammatory pathway targets relevant to cancer and immune disorders. The company was acquired by Celgene Corporation and rebranded as Celgene Research San Diego.

Summary

Signal Pharmaceuticals is a Biotech company based in San Diego, United States. Its most recent funding was a Series A round in Jan 1994. Investors include Accel, Venrock and Kleiner Perkins.

Funding History

AcquisitionJul 2000

Sign up to see all 3 rounds

Seed through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Signal Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/signal-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/signal-pharmaceuticals" alt="Signal Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>